Cargando…
miR-155 in the Resolution of Atherosclerosis
Atherosclerosis is a chronic progressive inflammatory disease where advanced lesions can eventually completely obstruct blood flow resulting in clinical events, such as a myocardial infarction or stroke. Monocytes and macrophages are the dominant biologically active immune cells involved in atherosc...
Autores principales: | Bruen, Robyn, Fitzsimons, Stephen, Belton, Orina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527595/ https://www.ncbi.nlm.nih.gov/pubmed/31139076 http://dx.doi.org/10.3389/fphar.2019.00463 |
Ejemplares similares
-
microRNA-155 Is Decreased During Atherosclerosis Regression and Is Increased in Urinary Extracellular Vesicles During Atherosclerosis Progression
por: Fitzsimons, Stephen, et al.
Publicado: (2020) -
Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium
por: Gomez, Ingrid, et al.
Publicado: (2020) -
Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis
por: Bruen, Robyn, et al.
Publicado: (2017) -
Hematopoietic miR155 Deficiency Enhances Atherosclerosis and Decreases Plaque Stability in Hyperlipidemic Mice
por: Donners, Marjo M. P. C., et al.
Publicado: (2012) -
Hypermethylation of the miR-155 gene in the whole blood and decreased plasma level of miR-155 in rheumatoid arthritis
por: Kolarz, Bogdan, et al.
Publicado: (2020)